Background
==========

The incidence of stroke in young adults is rising, and approximately 10--14% of all ischemic strokes occur in young adults aged 18--45 years \[[@b1-medscimonit-21-654]--[@b3-medscimonit-21-654]\]. Furthermore, post-stroke cognitive impairment, a decisive prognostic factor, is common \[[@b4-medscimonit-21-654]\] and may occur in up to 50% of young patients \[[@b5-medscimonit-21-654]\]. However, few studies address the cognition after stroke in young adults, especially the long term consequence \[[@b5-medscimonit-21-654]--[@b8-medscimonit-21-654]\].

Because of longer life expectancy, young stroke patients were informed about their cognitive prognosis, to recognize the risk factors of cognitive impairment may help to prevent the development of cognitive impairment. The present study aimed to investigate the long-term cognitive performance after ischemic stroke and the influence of baseline factors, treatments and functional outcome on this long-term cognitive outcome in young adults.

Material and Methods
====================

Consecutive patients with a first-ever ischemic stroke of presumed arterial origin, (age: 18--45 years) were recruited from XuanWu Hospital from January 1, 2006 to December 31, 2010.

Ischemic stroke was defined as the loss of brain function due to either blockage of a blood vessel via thrombosis or arterial embolism, or by cerebral hypoperfusion, and confirmed by CT or MRI. Primary exclusion criteria included cerebral venous sinus thrombosis, retinal infarction, hearing or listening comprehension disorder and death. There were additional exclusion criteria for cognitive assessment on the basis of neurological examinations ([Figure 1](#f1-medscimonit-21-654){ref-type="fig"}).

Information of patients with stroke was collected from medical records prospectively. Categories of the etiologies of ischemic stroke were large artery atherosclerosis (LAA), cardioembolism (CE), small artery occlusion (SAO), other determined etiologies (OD) and undetermined etiologies (UND) according to the Adams TOAST criteria \[[@b9-medscimonit-21-654]\]. The involvement of lesion vessel was divided into right or left anterior and posterior circulation. Following variables were recorded: 1) baseline information: age, gender and education years; 2) post-stroke treatments: antiplatelets, anticoagulants, and statins; 3) vascular risk factors: arterial hypertension, current smoking, alcohol abuse, abuse of other drugs (cocaine, heroin, etc.), diabetes mellitus, hyperlipidemia, coronary artery disease, non-ischemic cardiopathy, peripheral arterial disease, chronic or paroxysmal atrial fibrillation (AF), valvular heart disease, previously diagnosed migraine, obesity; 4) stroke severity on admission according to the National Institute of Health Stroke Scale (NIHSS); 5) etiologies of stroke (see above); 6) mean hospital stay; 7) duration of follow-up and 8) outcome: mortality and functional outcome at discharge assessed by mRS score. Poor outcome was defined as an mRS score of 3--6.

This protocol was approved by the Institutional Review Board and written informed consent was obtained from each subject, either directly or from his/her guardians, before study.

Cognitive assessment
--------------------

Cognitive assessment was performed between December 10, 2013 and the end of 2013 with the Modified Telephone Interview for Cognitive Status (TICS-m) by a trained interviewer over the telephone for each patient. The TICS-m includes following items: \[[@b10-medscimonit-21-654]\] 1) name, date, age, phone number (9 points); 2) counting backward (2 points); 3) first, a 10-word list learning exercise and then a delayed recall of that word list (10 points for each); 4) subtractions (5 points); 5) responsive naming (4 points); 6) repetition (2 points); 7) current President and Vice President (4 points); 8) finger tapping (2 points), and 9) word opposites (2 points), all of which are divided into four cognitive domains: 1) orientation; 2) registration, recent memory and delayed recall (memory); 3) attention/calculation; 4) semantic memory, comprehension and repetition (language). The total score is 50 points. Patients with a TICS-m score≤31 were considered a priori to have cognitive impairment \[[@b11-medscimonit-21-654]\].

In the Chinese version of the TICS-m, minor modifications are made for some items to make them more suitable for Chinese culture with the permission of the authors of original version \[[@b10-medscimonit-21-654]\]. For example, English words in verbal memory tests (item 5) and repetition task (item 8) were not translated into semantically equivalent Chinese ones. And the question for 'Vice President's name' (item 9) was also replaced with 'Prime Minister' name.

Statistical analysis
--------------------

All statistical analyses were performed using SPSS computerized statistics package (version 17.0). Data are expressed as means ± standard deviation (SD) or median or using descriptive statistics. Differences in all variables between the cognitive impairment group and normal cognition group were analyzed using the chi-square test for dichotomous outcome variables and one-way analysis of variance (ANOVA). Forward stepwise multiple logistic regression models for analysis all possible confounding factors in cognitive impairment in long-term follow-up. A value of P\<0.05 was considered statistically significant.

Results
=======

A total of 350 patients aged ≤45 years and having a first-ever cerebral infarction were studied. The demographic and clinical characteristics of these patients at baseline are described in [Table 1](#t1-medscimonit-21-654){ref-type="table"}. The mean age was 41.0±6.8 years at stroke onset, and 69.7% were men. The mean duration of follow-up was 5.8±3.2 years, whereas 53.4% had the duration of follow-up of ≥5 years.

The distribution of TICS-m scores at follow-up is shown in [Figure 2](#f2-medscimonit-21-654){ref-type="fig"}. About 39.4% of patients were diagnosed with cognitive impairment. The relationships between baseline prognostic factors and cognitive impairment were assessed in univariate analysis ([Table 1](#t1-medscimonit-21-654){ref-type="table"}). Advanced age, stroke severity on admission, a history of AF, and functional outcome at discharge (mRS \>2), left anterior circulation syndrome, stroke recurrence and LAA, UND subtype of TOAST were significantly associated with the cognitive impairment at follow-up. In multiple variable analysis ([Table 2](#t2-medscimonit-21-654){ref-type="table"}), stroke severity on admission, functional outcome at discharge (mRS \>2), left anterior circulation syndrome and stroke recurrence remained significant for subsequent cognitive impairment.

At follow-up, 92/350 subjects (26.3%) had an mRS \>2. This represented a reduction from 39.7% (139/350) at the time of discharge. Post-stroke cognition was also related to mRS at follow-up (*r*=−0.563, P\<0.001; [Figure 3](#f3-medscimonit-21-654){ref-type="fig"}). Moreover, stroke severity at follow-up (mRS \>2) was also significantly associated with post-stroke cognitive impairment (χ^2^=16.288, *P*\<0.001).

Discussion
==========

On the basis of a large hospital-based cohort, our study indicated that post-stroke cognitive impairment (PSCI) was related to the stroke severity on admission, left anterior circulation syndrome, stroke recurrence and the functional outcome, in both unadjusted and adjusted analyses.

Several studies, including a systematic review \[[@b4-medscimonit-21-654]\], have reported the associations of PSCI with functional outcome \[[@b6-medscimonit-21-654]\], stroke severity \[[@b12-medscimonit-21-654]--[@b15-medscimonit-21-654]\], and total anterior circulation syndrome \[[@b6-medscimonit-21-654]\], which were confirmed in the present study. Nevertheless, this study aimed to evaluate the long term cognition after stroke in young adults and the influence of mRS score on the long term cognition. Although available findings support a relationship between PSCI and functional outcome \[[@b14-medscimonit-21-654],[@b16-medscimonit-21-654]--[@b19-medscimonit-21-654]\], limited information is available on the relationship of short term cognition with functional outcome at discharge or at 3 months after stroke and the information is particularly limited in young stroke. Notwithstanding, evaluation at discharge or at 3 months is a significant limitation for a midterm outcome evaluation, and long term cognition is a decisive prognostic factor. Our study confirmed the strong relationship between PSCI and mRS, suggesting that interventions attenuate dependency, both in acute stroke and post stroke, and reduce subsequent cognitive decline. Moreover, young post-stroke patients were recruited as a representative control group for neuropsychological examinations.

Several studies have demonstrated the association between subacute PSCI and age \[[@b12-medscimonit-21-654]--[@b14-medscimonit-21-654],[@b16-medscimonit-21-654],[@b20-medscimonit-21-654],[@b21-medscimonit-21-654]\]. In our longer follow-up, age was not associated with a poor cognition state in young patients with ischemic stroke. Longer time interval is associated with an incident comorbidity that may interactively affect the cognitive performance \[[@b11-medscimonit-21-654],[@b14-medscimonit-21-654],[@b22-medscimonit-21-654]\]. Another explanation is the role of vascular lesions, and functional outcomes might be outstanding than neurodegenerative pathology in ischemic stroke patients.

The relationship of cognition with AF, TOAST and diabetes was less consistent across the TICS-m cognition measure. Several studies, albeit small, have reported the association of cognitive impairment with AF \[[@b13-medscimonit-21-654],[@b16-medscimonit-21-654],[@b20-medscimonit-21-654]\], diabetes \[[@b12-medscimonit-21-654],[@b15-medscimonit-21-654]\], and hippocampal atrophy \[[@b23-medscimonit-21-654]\]. Others studies also reveal an association with female gender \[[@b16-medscimonit-21-654],[@b22-medscimonit-21-654]\], prior stroke \[[@b14-medscimonit-21-654],[@b15-medscimonit-21-654],[@b24-medscimonit-21-654]\], hyperlipidemia \[[@b25-medscimonit-21-654],[@b26-medscimonit-21-654]\], and alcohol intake \[[@b20-medscimonit-21-654]\]. These factors were not risk factors of cognitive impairment in this study, because the risk factors were controlled in the long-term follow-up. Although the subtype of TOAST of ischemic stroke is independently associated with the survival and functional outcome \[[@b27-medscimonit-21-654],[@b28-medscimonit-21-654]\], an independent association between TOAST and subsequent cognitive impairment was not identified in the present study. In one study, the subtype of CE was found in up to 17% of patients and the subtype of UND was 36% \[[@b29-medscimonit-21-654]\]. However, in the present study, UND accounted for 43.7%, followed by LAA (23.8%), CE (8.3%), SAO (9.1%), and OD (15.1%). This may be ascribed to transesophageal echocardiography or transcranial Doppler not being performed which could have resulted in potential mechanisms, such as patent foramen ovale, not being identified.

Our study had several limitations. First, it was not a community-based study, and, therefore, our patients may not represent the young survivors with ischemic stroke. However, the age and sex standardized prevalence of stroke in our region is identical to that in China \[[@b14-medscimonit-21-654],[@b20-medscimonit-21-654]\]. We, therefore, speculate that our cohort has a good external validity and our population is representative to the young Chinese population with stroke. Second, the cognition was screened by telephone, rather than extensive neuropsychological testing, and the telephone assessment of cognition will be affected by some factors such as hearing loss and whether the participant or a caregiver delivered the responses. However, TICS-m includes the assessment of multiple cognitive domains covering memory, orientation, attention and language. Importantly, the prevalence of cognitive impairment in our study is comparable to that in other similar studies. Third, our study did not include employability and quality of life as longer standing important factors of cognition in the young stroke. As a retrospective study, our data collection is not perfect. But, we will consider these two factors in the future prospective studies.

Conclusions
===========

In young patients with ischemic stroke, long-term PSCI is common and associated with stroke severity on admission, left anterior circulation syndrome, stroke recurrence, and functional outcome. These factors are useful in clinical practice to identify subjects at a high risk for PSCI.
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###### 

Demographic and clinical characteristics and post-stroke treatments.

  Variables                     Cognitive impairment (n=138)   Normal cognition (n=212)   P
  ----------------------------- ------------------------------ -------------------------- ---------
  **Demographic data**                                                                    
  Age (mean ±SD, years)         42.1±7.6                       40.6±6.8                   0.038
  Age groups                                                                              0.741
   18--35 years                 33 (22.2)                      51 (24.1)                  
   36--45 years                 105 (77.8)                     161 (75.9)                 
  Gender (Male)                 102 (73.9)                     142 (67.0)                 0.628
  Education years (mean ±SD)    10.3±3.8                       11.0±3.2                   0.512
  NIHSS score on admission      8.6±2.5                        4.1±1.9                    \<0.001
  **Vascular risk factors**                                                               
  Obesity                       36 (26.1)                      37 (17.5)                  0.142
  Migraine                      3 (2.2)                        5 (2.4)                    1.0
  Arterial hypertension         76 (55.1)                      79 (37.3)                  0.218
  Diabetes mellitus             16 (11.6)                      15 (7.1)                   0.019
  Atrial fibrillation           10 (7.2)                       8 (3.8)                    \<0.001
  Nonischemic cardiopathy       2 (1.4)                        1 (0.5)                    0.817
  Coronary arterial disease     7 (5.1)                        11 (5.2)                   1.000
  Mechanical/biological         5 (3.6)                        3 (2.2)                    0.722
  **Valvular replacement**                                                                
  Dyslipidemia                  7 (5.1)                        11 (5.2)                   1.000
  Peripheral arterial disease   5 (3.6)                        7 (3.3)                    0.852
  Alcohol abuse                 60 (43.5)                      89 (42.0)                  0.894
  Current smoking               77 (55.8)                      140 (66.0)                 0.615
  Other drug abuses             3 (2.2)                        3 (1.4)                    0.461
  Active malignancy             2 (1.4)                        1 (0.5)                    0.117
  Homocysteine                  3 (2.2)                        4 (1.9)                    0.855
  Current puerperium            2 (1.4)                        2 (0.9)                    0.325
  Etiological stroke subtype                                                              0.011
   LAA                          63 (45.7)                      20 (9.4)                   \<0.001
   SAO                          15 (10.9)                      17 (8.0)                   0.251
   CE                           11 (8.0)                       18 (8.5)                   0.915
   OD                           24 (17.4)                      29 (13.7)                  0.323
   UND                          25 (18.1)                      128 (60.4)                 \<0.001
  **Sites of stroke**                                                                     
  Left anterior circulation     71 (51.4)                      81 (38.2)                  0.010
  Right anterior circulation    50 (36.2)                      98 (46.2)                  0.283
  Posterior circulation         17 (12.3)                      33 (15.6)                  0.525
  **Acute treatment**                                                                     
  Intravenous alteplase         37 (26.8)                      45 (21.2)                  0.211
  Follow-up duration                                                                      0.183
   \<5 years                    79 (57.2)                      84 (39.6)                  
   ≥5 years                     59 (42.8)                      128 (60.3)                 
  **Post-stroke treatment**                                                               
  Statin treatment              62 (45.0)                      74 (34.9)                  0.553
  Antiplatelet treatment        75 (54.3)                      81 (38.2)                  0.069
  Anticoagulation treatment     9 (6.5)                        12 (5.7)                   0.726
  **In-hospital outcome**                                                                 
  Hospital stay (days)          10.2±2.5                       8.3±2.4                    0.124
  mRS \>2 at discharge (%)      87 (63.0)                      52 (24.5)                  \<0.001
  Stroke recurrence (%)         49 (35.5)                      40 (18.9)                  0.006

###### 

Logistic regression analysis of cognitive impairment in long-term follow-up: multivariate analysis of baseline characteristics, stroke subtype and neurological status.

  Variables                            OR                   P
  ------------------------------------ -------------------- ---------
  NIHSS score on admission             3.44 (1.47--8.03)    0.004
  Stroke recurrence                    0.09 (0.01--0.63)    0.016
  Left anterior circulation syndrome   9.69 (2.56--36.72)   0.001
  mRS \>2 at discharge                 0.49 (0.41--0.60)    \<0.001
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